// App-Quantinova.ai

PO1581 : End-of-Study Results from ACQUIRE: A Study Measuring Quality of Life, Treatment Preference, and Treatment Satisfaction of Autosomal Dominant Polycystic Kidney Disease Patients in Europe

Researchers

Presenter

  • Joly Dominique

Principal Investigators

  • Doll Helen

  • De Jong-Laird Anne

  • Kabra Madhusudan

Medical Centers

  • Hematology Department, Necker Hospital, Paris, France

  • Clinical Outcomes Solutions, Folkestone, United Kingdom

  • Otsuka Pharmaceutical Europe Ltd Wexham Buckinghamshire United Kingdom

Locations

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

Disease

  • Autosomal dominant polycystic kidney disease

  • Chronic kidney disease

Biomarkers

  • Solute Carrier Family 26 Member 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Non Interventional

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved